Christopher SamlerChairman An entrepreneur and private equity investor with extensive CEO experience primarily in venture funded European healthcare companies. In 1997, he was appointed Weston Medical Group's first CEO and led it from concept through several rounds of funding to a full UK listing in 2000. Prior to this he was the inaugural CEO of Imutran, a Cambridge based healthcare company that was subsequently sold to Swiss pharmaceutical multinational, Novartis. Currently Christopher sits on the Board of a number of high growth business service and other companies. Christopher holds an MA from the University of Oxford and an MBA from the Harvard Business School and is co-founder of Iceni Capital, the private equity partnership focused on UK service-based growth companies. |